Macquarie Group LTD Puma Biotechnology, Inc. Transaction History

Macquarie Group LTD

$87.4 Billion
Q1 2024

A detailed history of Macquarie Group LTD transactions in Puma Biotechnology, Inc. stock. As of the latest transaction made, Macquarie Group LTD holds 62,784 shares of PBYI stock, worth $204,675. This represents 0.0% of its overall portfolio holdings.

Number of Shares

62,784

Previous 61,255 2.5%

Holding current value

$204,675

Previous $265,000 25.28%

% of portfolio

0.0%

Previous 0.0%

14 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 14, 2024	BUY	$4.29 - $7.4 $6,559 - $11,314	1,529 Added 2.5%	62,784 $332,000
Q4 2021 Feb 11, 2022	SELL	$2.85 - $6.58 $19,930 - $46,013	-6,993 Reduced 10.25%	61,255 $186,000
Q3 2021 Nov 12, 2021	BUY	$6.63 - $9.39 $42,127 - $59,664	6,354 Added 10.27%	68,248 $478,000
Q1 2021 May 14, 2021	SELL	$9.38 - $13.63 $2,842 - $4,129	-303 Reduced 0.49%	61,894 $601,000
Q2 2020 Aug 11, 2020	BUY	$7.01 - $13.24 $6,603 - $12,472	942 Added 1.54%	62,197 $649,000

Q4 2019 Feb 14, 2020	SELL	$6.5 - $10.73 $6.91 Million - $11.4 Million	-1,062,622 Reduced 94.55%	61,255 $536,000
Q3 2019 Nov 14, 2019	BUY	$8.75 - $12.85 $616,656 - $905,603	70,475 Added 6.69%	1,123,877 $12.1 Million
Q2 2019 Aug 14, 2019	BUY	$12.3 - $35.76 $814,678 - $2.37 Million	66,234 Added 6.71%	1,053,402 $13.4 Million
Q1 2019 May 15, 2019	BUY	$20.77 - $42.37 $3.36 Million - $6.86 Million	161,972 Added 19.63%	987,168 $38.3 Million
Q4 2018 Feb 15, 2019	BUY	$20.07 - $46.7 $3.55 Million - $8.25 Million	176,733 Added 27.25%	825,196 $16.8 Million
Q3 2018 Nov 15, 2018	BUY	$41.2 - $59.85 $7.24 Million - $10.5 Million	175,699 Added 37.16%	648,463 $29.7 Million
Q2 2018 Aug 14, 2018	BUY	$48.3 - $68.25 $22.8 Million - $32.3 Million	472,764 New	472,764 $28 Million
Q1 2018 May 11, 2018	SELL	$59.7 - $99.25 $17,910 - $29,775	-300 Closed	0 $0
Q4 2017 Feb 15, 2018	BUY	$93.85 - $132.45 $28,155 - $39,735	300	300 $30,000

Others Institutions Holding PBYI

# of Institutions

Shares Held

29.5M

Call Options Held

842K

Put Options Held

32.2K

View Full List

About PUMA BIOTECHNOLOGY, INC.

Ticker PBYI
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 45,556,000
Market Cap $149M
Description
Puma Biotechnology, Inc., a biopharmaceutical company, focuses on the development and commercialization of products to enhance cancer care in the United States and internationally. The company's drug candidates include PB272 neratinib (oral) for the patients with early stage HER2-overexpressed/amplified breast cancer; PB272 (neratinib, oral) for...

More about PBYI

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Macquarie Group LTD, based on Form 13F filings with the SEC.

News

Stay updated on Macquarie Group LTD with notifications on news.

Account

Macquarie Group LTD Puma Biotechnology, Inc. Transaction History